Products Categories
CAS No.: | 1099-87-2 |
---|---|
Name: | Sodium prasterone sulfate |
Article Data: | 2 |
Molecular Structure: | |
Formula: | C19H27NaO5S |
Molecular Weight: | 390.476 |
Synonyms: | Teloin;Androst-5-en-17-one, 3b-hydroxy-, hydrogen sulfate, sodium salt(6CI,7CI,8CI);DHA-S;DHEA sulfate sodium salt;Dehydroepiandrosterone sulfatesodium salt;Dehydroisoandrosterone sulfate sodium salt;Mylis;NSC 72822;Prasterone sodium sulfate;Sodium dehydroepiandrosterone sulfate;Sodiumdehydroepiandrosterone-3-sulfate;Sodium prasterone sulfate;Androst-5-en-17-one,3-(sulfooxy)-, sodium salt, (3b)- (9CI); |
EINECS: | 214-152-2 |
Melting Point: | 148-149 °C (dec.)(lit.) |
Flash Point: | 9℃ |
Appearance: | White to off-white powder |
Hazard Symbols: | F, C |
Risk Codes: | 11-34 |
Safety: | 16-26-36/37/39-45 |
PSA: | 91.88000 |
LogP: | 4.44450 |
Sodium prasterone sulfate
Conditions | Yield |
---|---|
With water; sodium chloride |
Conditions | Yield |
---|---|
With pyridine; chlorosulfonic acid at 22℃; for 2h; |
Conditions | Yield |
---|---|
at 25℃; |
Conditions | Yield |
---|---|
at 100℃; |
What can I do for you?
Get Best Price
IUPAC Name:sodium [(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] sulfate (1099-87-2)
Synonyms : Sodium dehydroepiandrosterone-3-sulfate
Product Categories: 17-Ketosteroids;Biochemistry ; Steroids
Molecular Structure: 1099-87-2
Molecular Formula: C19H27NaO5S
Molecular Weight : 390.47
CAS : 1099-87-2
EINECS: 214-152-2
Mol File: 1099-87-2.mol
Melting point: 148-149 °C (dec.)(lit.)
Refractive index : 10 ° (C=4, MeOH)
Solubility methanol: clear to hazy
Appearance: Sodium prasterone sulfate (1099-87-2) is color white to off-white powder
Merck : 2871
Sodium prasterone sulfate (1099-87-2) is used as endogenous adrenal androgens.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravaginal | > 500mg/kg (500mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 40, Pg. 444, 1998. | |
mouse | LD50 | intraperitoneal | 460mg/kg (460mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA | Kiso to Rinsho. Clinical Report. Vol. 10, Pg. 1852, 1976. |
mouse | LD50 | intravaginal | > 500mg/kg (500mg/kg) | Oyo Yakuri. Pharmacometrics. Vol. 48, Pg. 189, 1994. | |
mouse | LD50 | intravenous | 274mg/kg (274mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: ATAXIA | Kiso to Rinsho. Clinical Report. Vol. 10, Pg. 1852, 1976. |
mouse | LD50 | oral | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. 6, Pg. 687, 1982. | |
mouse | LD50 | subcutaneous | 899mg/kg (899mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA | Kiso to Rinsho. Clinical Report. Vol. 10, Pg. 1852, 1976. |
rat | LD50 | intraperitoneal | 523mg/kg (523mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA | Kiso to Rinsho. Clinical Report. Vol. 10, Pg. 1852, 1976. |
rat | LD50 | intravaginal | > 500mg/kg (500mg/kg) | Oyo Yakuri. Pharmacometrics. Vol. 48, Pg. 189, 1994. | |
rat | LD50 | intravenous | 468mg/kg (468mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Kiso to Rinsho. Clinical Report. Vol. 10, Pg. 1852, 1976. |
rat | LD50 | oral | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. 6, Pg. 687, 1982. | |
rat | LD50 | subcutaneous | 1005mg/kg (1005mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA | Kiso to Rinsho. Clinical Report. Vol. 10, Pg. 1852, 1976. |
women | TDLo | intravenous | 4mg/kg (4mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Japan Medical Gazette. Vol. 18(5), Pg. 10, 1981. |
Hazard Codes : F,C
Risk Statements: 11-34
11: Highly Flammable
34: Sodium prasterone sulfate (1099-87-2) can causes burns.
Safety Statements: 16-26-36/37/39-45
16: Keep away from sources of ignition - No smoking
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36/37/39: Wear suitable protective clothing, gloves and eye/face protection
WGK Germany: 3
RTECS : BV8397400